Cidara Therapeutics Inc
NASDAQ:CDTX
Cidara Therapeutics Inc
NASDAQ:CDTX
Price:
13.61 USD
8.79%
Market Closed
Updated:
May 7, 2024
Cidara Therapeutics Inc
Cash from Investing Activities
|
Cidara Therapeutics Inc
Cash from Investing Activities Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Cidara Therapeutics Inc
NASDAQ:CDTX
|
Cash from Investing Activities
-$505k
|
CAGR 3-Years
-39%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Cash from Investing Activities
-$2B
|
CAGR 3-Years
62%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash from Investing Activities
-$2.3B
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-76%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Investing Activities
-$26.2B
|
CAGR 3-Years
-69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash from Investing Activities
-$3.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-73%
|
CAGR 10-Years
-50%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash from Investing Activities
-$3.2B
|
CAGR 3-Years
-256%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-25%
|
See Also
What is Cidara Therapeutics Inc's Cash from Investing Activities?
Cash from Investing Activities
-505k
USD
-505k
USD
Based on the financial report for Dec 31, 2023, Cidara Therapeutics Inc's Cash from Investing Activities amounts to -505k USD.
What is Cidara Therapeutics Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
-39%
-39%
Over the last year, the Cash from Investing Activities growth was -321%. The average annual Cash from Investing Activities growth rates for Cidara Therapeutics Inc have been -39% over the past three years .
You don't have any saved screeners yet
